Carrie's practice involves a variety of transactional, regulatory, and fraud and abuse matters.
Carrie's transactional experience focuses on advising health care clients on joint ventures, mergers and acquisitions, service agreements, and corporate stock and asset acquisitions. She has served as corporate and regulatory counsel to pharmacy benefit managers, retail pharmacies, and health care providers in acquisitions, which included due diligence, licensing, change of ownership, and contracting. Carrie has also assisted in the preparation and negotiation of pharmacy benefit manager agreements, pharmacy network agreements, pharmaceutical distribution agreements, and rebate agreements.
She also advises health care clients on a variety of regulatory issues, such as federal and state anti-kickback and self-referral laws, and state regulatory issues, including corporate practice of medicine and fee-splitting prohibitions, telemedicine and online prescribing requirements, certificate of need applications, and laboratory billing restrictions.
Carrie provides compliance advice to clients in structuring proposed transactions and business arrangements to comply with the anti-kickback statute and the Stark fraud and abuse laws as well as other applicable state and federal regulatory requirements. Carrie has counseled a wide range of health care providers, including pharmacies, renal dialysis providers, pharmacy benefit managers, physicians and physician groups, mental health providers, health care clinics, laboratories, hospital systems, practice management companies, and life sciences companies.
Before attending law school, Carrie worked as a microbiologist at the National Institutes of Health.
•Co-author, IRS Ruling Permits Inclusion of “Friendly PCs” in Consolidated Federal Income Tax Returns, Health Care Alert (02.13.2015)
•Co-author, What is the Anti-Kickback Statute?, American Bar Association (2015)
•Co-author, OIG Special Advisory Bulletin Provides Guidance on Application of Federal Anti-Kickback Statute to Pharmaceutical Manufacturer Copayment Coupons, BNA's Health Care Fraud Report (10.15.2014)
•Co-author, Proposed Rule Issued by OIG Realigns Its Enforcement Views with Health Care Reform Goals, Health Care Alert (10.09.2014)
•Co-author, The Medical Home - A New Foundation for Health Care, Health Care Reform Advisory (01.04.2010)
•The Human Papillomavirus Vaccine: Should It Be Mandatory or Voluntary?, Journal of Health Care Law & Policy (2007)